MedPage Today on MSN
Aspects fails to reflect ceiling for endovascular stroke therapy benefit
Quantitative volumetry better avoids futile reperfusion, per a nationwide study ...
Thrombolytic agents, including tenecteplase, are generally used within 4.5 hours after the onset of stroke symptoms. Information on whether tenecteplase confers benefit beyond 4.5 hours is limited. We ...
The most common scale used to evaluate outcome of neurosurgical procedures, the modified rankin scale (mRS) – does not measure what is commonly assumed, concludes a study conducted at the Department ...
Adverse nonmotor outcomes are prevalent in younger adults up to 6 months after stroke — even in those with favorable functional recovery scores on standard scales. In a prospective trial of about 500 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results